Exhibit 99.02
[Cardinal Health Logo]
7000 Cardinal Place
Dublin, OH 43017
www.cardinal.com
FOR IMMEDIATE RELEASE
CONTACTS:
Media: Jim Mazzola Investors: Jim Hinrichs
(614) 757-3690 (614) 757-7828
jim.mazzola@cardinal.com jim.hinrichs@cardinal.com
CARDINAL HEALTH FORM 10-K FILING DELAYED
DUBLIN, OHIO, SEPT. 27, 2004 - Cardinal Health, Inc. (NYSE: CAH), announced
today that the filing of its Form 10-K for the fiscal year ended June 30 will be
delayed to provide additional time for its Audit Committee to complete an
investigation of certain matters related to its ongoing internal review. Pending
satisfactory review of these matters, the company's goal is to file its Form
10-K by late October.
These matters are not expected to change the guidance Cardinal Health provided
on June 30 for its fourth quarter and fiscal year 2004 or the outlook it
provided for fiscal year 2005 on Sept. 13.
As a result of the delay in its Form 10-K filing, Cardinal Health intends to
postpone its annual meeting of shareholders from Nov. 3 to a date as soon as
possible following the filing of its Form 10-K.
As previously reported, in October 2003, the SEC initiated an informal inquiry
regarding Cardinal Health seeking historical financial and related information.
In May, the company was notified that the SEC had converted the informal inquiry
into a formal investigation. In June, as part of the SEC's formal investigation,
Cardinal Health received an SEC subpoena that included a request for the
production of documents relating to revenue classification, and the methods used
for such classification, in the company's Pharmaceutical Distribution business
as either "Operating Revenues" or "Bulk Deliveries to Customer Warehouses and
Other." In addition, the company learned that the U.S. Attorney for the Southern
District of New York had also commenced an inquiry that the company understands
relates to the revenue classification issue. Cardinal Health continues to
respond to the investigations by providing all information required.
ABOUT CARDINAL HEALTH
Cardinal Health, Inc. (www.cardinal.com) is the leading provider of products and
services supporting the health care industry. Cardinal Health develops,
manufactures, packages and markets products for patient care; develops
drug-delivery technologies; distributes pharmaceuticals and medical, surgical
and laboratory supplies; and offers
CARDINAL HEALTH FORM 10-K FILING DELAYED
PAGE 2
consulting and other services that improve quality and efficiency in health
care. Headquartered in Dublin, Ohio, Cardinal Health employs more than 55,000
people on six continents and produces annual revenues of more than $50 billion.
Cardinal Health is ranked No.17 on the current Fortune 500 list and named one of
the best U.S. companies by Forbes magazine for 2004.
Except for historical information, all other information in this news release
consists of forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These forward-looking statements are
subject to risks and uncertainties that could cause actual results to differ
materially from those projected, anticipated or implied. The most significant of
these uncertainties are described in Cardinal Health's Form 10-K, Form 8-K and
Form 10-Q reports (including all amendments to those reports) and exhibits to
those reports, and include (but are not limited to) the costs, difficulties, and
uncertainties related to the integration of acquired businesses, the loss of one
or more key customer or supplier relationships or changes to the terms of those
relationships, changes in the distribution patterns or reimbursement rates for
health-care products and/or services, the results, effects or timing of any
inquiry or investigation by any regulatory authority or any legal and
administrative proceedings, and general economic and market conditions. Cardinal
Health undertakes no obligation to update or revise any forward-looking
statement.